Skip to main content
. 2020 Nov 2;20(14):1–148.

Table A8:

New-Onset Atrial Fibrillation

Author, Year
N (TAVI/SAVR)		 30 Days 1 Year
Mack et al, 201918
950 (496/454)

PARTNER 3		 KM estimate,a n (%)

  • TAVI: 21 (5.0)

  • SAVR: 145 (39.5)


HR (95% CI)
0.10 (0.06–0.16)
RD (95% CI)
−27.7% (−32.3% to −23.1%)		 KM estimate,a n (%)

  • TAVI: 29 (7.0)

  • SAVR: 150 (40.9)


HR (95% CI)
0.13 (0.09–0.20)
RD (95% CI)
−27.7% (−32.0% to −22.0%)
Popma et al, 201917
1,403 (725/678)

Evolut LRT		 TAVI: 7.7%b
SAVR: 35.4%b
RD (95% BCrI)
−27.7 (−31.8 to −23.6)		 TAVI: 9.8%b
SAVR: 38.3%b
RD (95% BCrI)
−28.5 (−32.8 to −24.1)

Abbreviations: BCrI, Bayesian credible interval; CI; confidence interval; KM; Kaplan-Meier; RD, risk difference; HR hazard ratio; RD, risk difference; SAVR, surgical aortic valve replacement; TAVI, transcatheter aortic valve implantation.

a

Percentages provided are Kaplan-Meier estimates at the specific time point and do not necessarily equal number of patients who experienced event divided by total number of patients in treatment group at given time point.

b

Calculated by means of Bayesian analyses.